MCRB
Seres Therapeutics, Inc.
NASDAQHealthcareBiotechnologyUS
Rating:D+
Company Profile
CEO
Richard N. Kender
IPO Date
2015-06-26
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Seres Therapeutics, Inc.
CEO
Richard N. Kender
IPO Date
2015-06-26
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
| $7.53 |
| 19 May 2026 | Shaff Eric D. | director | M-Exempt | Disposed | 391 | $0.00 |
| 19 May 2026 | Shaff Eric D. | director | M-Exempt | Disposed | 331 | $0.00 |
| 19 May 2026 | DesRosier Thomas | See Remarks | M-Exempt | Acquired | 244 | $0.00 |
| 19 May 2026 | DesRosier Thomas | See Remarks | S-Sale | Disposed | 79 | $7.53 |
| 19 May 2026 | DesRosier Thomas | See Remarks | M-Exempt | Disposed | 133 | $0.00 |
| 19 May 2026 | DesRosier Thomas | See Remarks | M-Exempt | Disposed | 111 | $0.00 |
| 19 May 2026 | Brady Kelly | See Remarks | M-Exempt | Acquired | 180 | $0.00 |
| 19 May 2026 | Brady Kelly | See Remarks | S-Sale | Disposed | 59 | $7.53 |